Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105161Phase 4Not yet recruiting
Phase 4, randomised trial of lidocaine, esketamine, sufentanil, tramadol and ibuprofen in postoperative respiratory complications (PRC), postoperative pain, postoperative delirium (POD) and 1 more (2 arms), sponsored by The First College of Clinical Medical Science, China Three Gorges University. Primary endpoint: Perioperative adverse respiratory events (PRAE). Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105161.